SIMLANDI
Live / Allowed — Publication / registration review complete (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99425494
- Mark type
- Design + words
- Filed
- 02 Oct 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune diseases
Owner
- Teva Pharmaceuticals USA, Inc., Parsippany, NJ, US
Prior registrations
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 10 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 10 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 03 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Mar 2026 — NON-FINAL ACTION E-MAILED
- 03 Mar 2026 — NON-FINAL ACTION WRITTEN
- 24 Feb 2026 — ASSIGNED TO EXAMINER
- 23 Feb 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 23 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED